PEMBROLIZUMAB
2014-HNCG
Phase 3 small_molecule active
Quick answer
PEMBROLIZUMAB for Squamous cell carcinoma of head and neck is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Squamous cell carcinoma of head and neck
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active